The antifibrotic properties of ACEi have been shown in other models of renal fibrosis [27] as it is known that overactivation of RAS, mainly by the action of Ang II, is an important contributor to the pathogenesis of hypertension and it has profibrotic effects that contribute to the progression of chronic kidney disease [7]. The gene discussed is AGT; the disease is hypertensive disorder.